Changing the rules of the game. Steve Bates, CEO, BIA




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Changing the rules of the game. Steve Bates, CEO, BIA
Released on: June 27, 2014. © PTV
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    Steve Bates, CEO, BIA talks to Nigel Borshell about their involvement in the European Adaptive Licensing scheme and the UK's Early Access scheme and how these initiatives can help companies find a new path to market or way to bring their drugs forward which will ultimately benefit patients.
  • Summary
  • Transcript
  • Participants
  • Company
Steve Bates, CEO, BIA talks to Nigel Borshell about their involvement in the European Adaptive Licensing scheme and the UK's Early Access scheme and how these initiatives can help companies find a new path to market or way to bring their drugs forward which will ultimately benefit patients.
The UK is one of the best places in the world for life sciences, on a par with premier life science destinations such as Boston, San Francisco, San Diego and Singapore. Focussing on the need for access to finance for the British Biotec industry and regulatory reform for drug development and drug discovery the BIA works with other parties helping to shape a better environment for the UK bioscience sector. Steve Bates, CEO, BIA talks to Nigel Borshell about their involvement in the European Adaptive Licensing scheme and the UK's Early Access scheme and how these initiatives can help companies find a new path to market or way to bring their drugs forward which will ultimately benefit patients.
Steve Bates
BIA
BioIndustry Association (BIA)